Schedule a consultation
During your consultation with your ACPS med spa provider, we will examine your unique characteristics in order to recommend the best non-surgical methods to restore a youthful, refreshed appearance.
At ACPS, our goal is to help you become the best version of yourself. Each patient’s aesthetic journey is customized and ACPS is excited to now offer medical weight loss as a part of that journey.
Our weightloss program is geared towards getting patients surgery ready and/or to help them maintain their surgical results. Semaglutide is the prescription medication that ACPS prescribes, along with diet and exercise to help patients lose weight and achieve their goals.
We advise that all patients be as close to their ideal weight, as possible, before having surgery. For certain ages, health histories and type of surgical procedure there might be a BMI [body mass index] requirement before surgery will be allowed at ACPS.
A BMI requirement could also vary from surgeon to surgeon at ACPS. This is because there is no one-size fits all surgery and a BMI restriction is for the safety of the patient and discussed at length during the consultation process while going over each patient’s unique health history and desired outcomes.
The ACPS weight loss program is ideal for patients who are ready to take the next steps towards plastic surgery but have a BMI between 25 – 45 and their surgeon is suggesting weight loss prior to proceeding with surgery.
There are many benefits to being closer to your ideal weight prior to surgery, those include:
Medical weight loss isn’t just for patients who are looking to have surgery, it can also benefit recent surgical patients who are looking for ways to maintain their results. Adjusting to your new body after surgery can be scary. The right diet and exercise can help maintain results and utilizing our medical weight loss can jump start your post-surgical journey for a beautiful body for years to come.
Semaglutide is a prescription medication that ACPS uses, along with diet and exercise, to help patients lose weight. Semaglutide, sold under the brand names Wegovy and Ozempic among others, is an antidiabetic medication used for the treatment of type 2 diabetes and long-term weight management. Ozempic was FDA approved for the treatment of type 2 diabetes in 2017. Wegovy was FDA approved for the treatment of long-term weight management in 2021.
Semaglutide is an injectable medication that can help balance out hormones, like insulin, which can curb appetite and decrease food intake. This can help patients eat fewer calories, which can lead to weight loss.
Medical weight loss is the use of prescribed medication to help lose weight while being supervised by a physician during the weight loss journey.
ACPS wants to help patients throughout their aesthetic journey.
Body Mass Index (BMI) is a person’s weight in kilograms (or pounds) divided by the square of height in meters (or feet). BMI is an inexpensive and easy screening method for weight category—underweight, healthy weight, overweight, and obesity. You can calculate your BMI here.
For example, a female who is 5’ 9” and weighs 132 pounds has a BMI of 19.5 and is considered to have a normal or healthy weight. At that same height, 5’ 9”, a female patient with a weight of 176, has a BMI of 26 and is considered overweight.
Many plastic surgeons have BMI requirements, but it will vary from office to office and surgeon to surgeon. If you have a high BMI and want plastic surgery, it’s important to research and find a board-certified plastic surgeon who has experience operating on high BMI patients. They can perform a thorough consultation and determine if you are a good candidate for plastic surgery. It’s important to set the right expectations for results when operating on a patient with a high BMI.
The short answer is that many of our patients lose weight in the first week of taking Semaglutide. The first dose is small. It is primarily used to gently introduce the medication to the body without risking developing severe side effects.
However, weight loss is not just one thing in other words, it Is possible that without making any lifestyle changes or thinking it’s not possible to overindulge, any results from a weight loss medication could be voided.
Healthy sustainable weight loss is 0.5 – 2.0 pounds a week.
The STEP 1 study for Wegovy lasted for 68 weeks. Unfortunately, we have no follow-up information from those patients to assess whether study participants maintained their weight loss after stopping the medication. The average weight loss achieved in the STEP 1 study of Semaglutide for weight loss was 14.9% of the initial body weight over 68 weeks.
The ACPS program is customized to each patient’s needs. We recommend a 16-week program and to assess results and determine a continued game plan at that time. A 2nd round of 16 weeks might be needed.
ACPS does not offer Semaglutide for extended use for weight loss alone.
While no medication is without risks and side effects, Semaglutide is relatively safe for most people.
The most common side effects of Semaglutide may include: nausea, diarrhea, vomiting, constipation, stomach (abdomen) pain, headache, tiredness (fatigue), upset stomach, dizziness, feeling bloated, belching, gas, stomach flu and heartburn.
NOTICE: Are there any contraindications?
NOTICE: Before using semaglutide tell your healthcare provider if you have any other medical conditions, including if you:
NOTICE: Semaglutide may cause serious side effects, including: